A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the Netherlands

First published 01/10/2015

Last updated 23/04/2024

EU PAS number:

EUPAS11141

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

16646_PHARMO_Rivaroxaban protocol

English (702.54 KB - PDF)View document

Study results

Study results

EUPAS11141-43170

English (152.16 KB - PDF)View document

Study report

Study report

16646_Progress Report_v1.0_2019-01-28

English (93.28 KB - PDF)View document

EUPAS11141-43221

English (592.92 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents